ID   CTDSL_HUMAN             Reviewed;         276 AA.
AC   O15194; Q3ZTU0; Q70KI4; Q7Z5Q2;
DT   13-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 2.
DT   15-MAR-2017, entry version 131.
DE   RecName: Full=CTD small phosphatase-like protein;
DE            Short=CTDSP-like;
DE            EC=3.1.3.16;
DE   AltName: Full=Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3;
DE   AltName: Full=NIF-like protein;
DE   AltName: Full=Nuclear LIM interactor-interacting factor 1;
DE            Short=NLI-interacting factor 1;
DE   AltName: Full=Protein YA22;
DE            Short=hYA22;
DE   AltName: Full=RBSP3;
DE   AltName: Full=Small C-terminal domain phosphatase 3;
DE            Short=SCP3;
DE            Short=Small CTD phosphatase 3;
GN   Name=CTDSPL; Synonyms=C3orf8, NIF1, NIFL, SCP3, YA22;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain, Lung, and Pancreas;
RX   PubMed=9179494; DOI=10.1093/dnares/4.1.35;
RA   Ishikawa S., Kai M., Tamari M., Takei Y., Takeuchi K., Bandou H.,
RA   Yamane Y., Ogawa M., Nakamura Y.;
RT   "Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3
RT   that is homozygously deleted in a lung carcinoma cell line.";
RL   DNA Res. 4:35-43(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RX   PubMed=12721286; DOI=10.1074/jbc.M301791200;
RA   Yeo M., Lin P.S., Dahmus M.E., Gill G.N.;
RT   "A novel RNA polymerase II C-terminal domain phosphatase that
RT   preferentially dephosphorylates serine 5.";
RL   J. Biol. Chem. 278:26078-26085(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS PRO-121;
RP   SER-127 AND GLY-132.
RC   TISSUE=Lung;
RX   PubMed=15051889; DOI=10.1073/pnas.0401238101;
RA   Kashuba V.I., Li J., Wang F., Senchenko V.N., Protopopov A.,
RA   Malyukova A., Kutsenko A.S., Kadyrova E., Zabarovska V.I.,
RA   Muravenko O.V., Zelenin A.V., Kisselev L.L., Kuzmin I., Minna J.D.,
RA   Winberg G., Ernberg I., Braga E., Lerman M.I., Klein G.,
RA   Zabarovsky E.R.;
RT   "RBSP3 (HYA22) is a tumor suppressor gene implicated in major
RT   epithelial malignancies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:4906-4911(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=16533400; DOI=10.1186/1471-2164-7-48;
RA   Kemmer D., Podowski R.M., Arenillas D., Lim J., Hodges E., Roth P.,
RA   Sonnhammer E.L.L., Hoeoeg C., Wasserman W.W.;
RT   "NovelFam3000 -- uncharacterized human protein domains conserved
RT   across model organisms.";
RL   BMC Genomics 7:48-48(2006).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15681389; DOI=10.1126/science.1100801;
RA   Yeo M., Lee S.-K., Lee B., Ruiz E.C., Pfaff S.L., Gill G.N.;
RT   "Small CTD phosphatases function in silencing neuronal gene
RT   expression.";
RL   Science 307:596-600(2005).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 82-265, AND SUBUNIT.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
CC   -!- FUNCTION: Recruited by REST to neuronal genes that contain RE-1
CC       elements, leading to neuronal gene silencing in non-neuronal cells
CC       (By similarity). Preferentially catalyzes the dephosphorylation of
CC       'Ser-5' within the tandem 7 residue repeats in the C-terminal
CC       domain (CTD) of the largest RNA polymerase II subunit POLR2A.
CC       Negatively regulates RNA polymerase II transcription, possibly by
CC       controlling the transition from initiation/capping to processive
CC       transcript elongation. {ECO:0000250, ECO:0000269|PubMed:12721286}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 1 Mg(2+) ion per monomer. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with REST (By similarity). Monomer.
CC       {ECO:0000250, ECO:0000269|PubMed:18058037}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HYA22B;
CC         IsoId=O15194-1; Sequence=Displayed;
CC       Name=2; Synonyms=HYA22A;
CC         IsoId=O15194-2; Sequence=VSP_011541;
CC   -!- TISSUE SPECIFICITY: Expression is restricted to non-neuronal
CC       tissues. {ECO:0000269|PubMed:15681389}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA21667.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D88153; BAA21667.1; ALT_INIT; mRNA.
DR   EMBL; AY279532; AAP34400.1; -; mRNA.
DR   EMBL; AJ575644; CAE11804.1; -; mRNA.
DR   EMBL; AJ575645; CAE11805.1; -; mRNA.
DR   EMBL; AY364238; AAQ76797.1; -; mRNA.
DR   CCDS; CCDS33734.1; -. [O15194-1]
DR   CCDS; CCDS33735.1; -. [O15194-2]
DR   PIR; JC5707; JC5707.
DR   RefSeq; NP_001008393.1; NM_001008392.1. [O15194-1]
DR   RefSeq; NP_005799.2; NM_005808.2. [O15194-2]
DR   UniGene; Hs.475963; -.
DR   PDB; 2HHL; X-ray; 2.10 A; A/B/C/D=82-265.
DR   PDBsum; 2HHL; -.
DR   ProteinModelPortal; O15194; -.
DR   SMR; O15194; -.
DR   BioGrid; 115512; 7.
DR   DIP; DIP-61247N; -.
DR   IntAct; O15194; 2.
DR   STRING; 9606.ENSP00000273179; -.
DR   DEPOD; O15194; -.
DR   iPTMnet; O15194; -.
DR   PhosphoSitePlus; O15194; -.
DR   SwissPalm; O15194; -.
DR   BioMuta; CTDSPL; -.
DR   MaxQB; O15194; -.
DR   PaxDb; O15194; -.
DR   PeptideAtlas; O15194; -.
DR   PRIDE; O15194; -.
DR   DNASU; 10217; -.
DR   Ensembl; ENST00000273179; ENSP00000273179; ENSG00000144677. [O15194-1]
DR   Ensembl; ENST00000443503; ENSP00000398288; ENSG00000144677. [O15194-2]
DR   GeneID; 10217; -.
DR   KEGG; hsa:10217; -.
DR   UCSC; uc003chg.4; human. [O15194-1]
DR   CTD; 10217; -.
DR   DisGeNET; 10217; -.
DR   GeneCards; CTDSPL; -.
DR   HGNC; HGNC:16890; CTDSPL.
DR   HPA; HPA048325; -.
DR   MIM; 608592; gene.
DR   neXtProt; NX_O15194; -.
DR   OpenTargets; ENSG00000144677; -.
DR   PharmGKB; PA128394571; -.
DR   eggNOG; KOG1605; Eukaryota.
DR   eggNOG; COG5190; LUCA.
DR   GeneTree; ENSGT00390000017194; -.
DR   HOGENOM; HOG000236379; -.
DR   HOVERGEN; HBG053298; -.
DR   InParanoid; O15194; -.
DR   KO; K15731; -.
DR   OrthoDB; EOG091G0J49; -.
DR   PhylomeDB; O15194; -.
DR   TreeFam; TF313556; -.
DR   SIGNOR; O15194; -.
DR   ChiTaRS; CTDSPL; human.
DR   EvolutionaryTrace; O15194; -.
DR   GeneWiki; CTDSPL; -.
DR   GenomeRNAi; 10217; -.
DR   PRO; PR:O15194; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000144677; -.
DR   CleanEx; HS_CTDSPL; -.
DR   ExpressionAtlas; O15194; baseline and differential.
DR   Genevisible; O15194; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IBA:GO_Central.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR011948; Dullard_phosphatase.
DR   InterPro; IPR004274; FCP1_dom.
DR   InterPro; IPR023214; HAD-like_dom.
DR   Pfam; PF03031; NIF; 1.
DR   SMART; SM00577; CPDc; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02251; HIF-SF_euk; 1.
DR   PROSITE; PS50969; FCP1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Hydrolase;
KW   Magnesium; Metal-binding; Nucleus; Polymorphism; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN         1    276       CTD small phosphatase-like protein.
FT                                /FTId=PRO_0000212569.
FT   DOMAIN      102    260       FCP1 homology. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00336}.
FT   ACT_SITE    112    112       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE    114    114       Proton donor. {ECO:0000250}.
FT   METAL       112    112       Magnesium. {ECO:0000250}.
FT   METAL       114    114       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       223    223       Magnesium. {ECO:0000250}.
FT   SITE        168    168       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   SITE        206    206       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   VAR_SEQ      79     89       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12721286,
FT                                ECO:0000303|PubMed:15051889,
FT                                ECO:0000303|PubMed:16533400,
FT                                ECO:0000303|PubMed:9179494}.
FT                                /FTId=VSP_011541.
FT   VARIANT     121    121       S -> P. {ECO:0000269|PubMed:15051889}.
FT                                /FTId=VAR_019683.
FT   VARIANT     127    127       N -> S. {ECO:0000269|PubMed:15051889}.
FT                                /FTId=VAR_019684.
FT   VARIANT     132    132       V -> G. {ECO:0000269|PubMed:15051889}.
FT                                /FTId=VAR_019685.
FT   STRAND       93     96       {ECO:0000244|PDB:2HHL}.
FT   HELIX       101    103       {ECO:0000244|PDB:2HHL}.
FT   STRAND      108    111       {ECO:0000244|PDB:2HHL}.
FT   TURN        115    117       {ECO:0000244|PDB:2HHL}.
FT   STRAND      118    123       {ECO:0000244|PDB:2HHL}.
FT   STRAND      129    136       {ECO:0000244|PDB:2HHL}.
FT   STRAND      139    147       {ECO:0000244|PDB:2HHL}.
FT   HELIX       151    161       {ECO:0000244|PDB:2HHL}.
FT   STRAND      162    167       {ECO:0000244|PDB:2HHL}.
FT   HELIX       172    182       {ECO:0000244|PDB:2HHL}.
FT   STRAND      188    192       {ECO:0000244|PDB:2HHL}.
FT   HELIX       194    196       {ECO:0000244|PDB:2HHL}.
FT   STRAND      198    200       {ECO:0000244|PDB:2HHL}.
FT   STRAND      203    205       {ECO:0000244|PDB:2HHL}.
FT   HELIX       208    210       {ECO:0000244|PDB:2HHL}.
FT   STRAND      211    213       {ECO:0000244|PDB:2HHL}.
FT   HELIX       215    217       {ECO:0000244|PDB:2HHL}.
FT   STRAND      218    223       {ECO:0000244|PDB:2HHL}.
FT   HELIX       225    228       {ECO:0000244|PDB:2HHL}.
FT   HELIX       232    234       {ECO:0000244|PDB:2HHL}.
FT   STRAND      235    237       {ECO:0000244|PDB:2HHL}.
FT   HELIX       249    261       {ECO:0000244|PDB:2HHL}.
SQ   SEQUENCE   276 AA;  31129 MW;  5C7B32A1127B0F59 CRC64;
     MDGPAIITQV TNPKEDEGRL PGAGEKASQC NVSLKKQRSR SILSSFFCCF RDYNVEAPPP
     SSPSVLPPLV EENGGLQKGD QRQVIPIPSP PAKYLLPEVT VLDYGKKCVV IDLDETLVHS
     SFKPISNADF IVPVEIDGTI HQVYVLKRPH VDEFLQRMGQ LFECVLFTAS LAKYADPVAD
     LLDRWGVFRA RLFRESCVFH RGNYVKDLSR LGRELSKVII VDNSPASYIF HPENAVPVQS
     WFDDMTDTEL LDLIPFFEGL SREDDVYSML HRLCNR
//
